It's How Medicine Should Be®
<< Previous | New Search | Return to Search Results | Next >>

Physician Profile


call (888) 352-RUSH for help arranging an appointment

Ali Keshavarzian, MD

Patient Feedback
  • Gastroenterology
  • Internal Medicine
Board Certification:
  • Gastroenterology
  • Internal Medicine
Faculty Rank: Professor
Medical or Graduate Education: Tehran University School of Medical Sciences, Iran
Residency: Guy's Hospital, England - Internal Medicine
  Hillingdon Hospital, England - Gastroenterology
Fellowship: Royal Postgraduate Medical School, England - Gastroenterology
  University of Maryland Medical Center - Gastroenterology
Clinical Expertise:
  • Blood in stool
  • Colonoscopy
  • Crohn's disease
  • Esophagogastroduodenoscopy (EGD)
  • Fistula
  • Irritable bowel syndrome (IBS)
  • Leaky gut syndrome
  • Pouchitis
  • Ulcerative colitis
Research Interests:
  • Inflammatory bowel disease
  • Oxygen free radicals in gastrointestinal disease
  • Regulation of intestinal barrier function
  • Gut microbiota in GI and systemic diseases
  • Prebiotic and gastrointestinal diseases
  • Effect of alcohol on intestine
  • Mind-body stress in gastrointestinal diseases
  • Sleep, circadian rhythm and gastrointestinal diseases
  • Brain/Gut Axis
  • Parkinson''s disease and Gut
Languages Spoken:
  • Farsi
Google Map
Google Map

Below is a list of scientific publications for which this practitioner was either the primary author or a contributor. Citations come from PubMed, a database of biomedical literature, life science journals and online books. PubMed is a service of the US Library of Medicine at the National Institutes of Health. Click on the title of the cited work for more information (this will take you directly to Listings go back five years.

  1. Colonic bacterial composition in Parkinson's disease.
    Keshavarzian A, Green SJ, Engen PA, Voigt RM, Naqib A, Forsyth CB, Mutlu E, Shannon KM
    Mov. Disord.
    2015 Sep
  2. The Role of miR-212 and iNOS in Alcohol-Induced Intestinal Barrier Dysfunction and Steatohepatitis.
    Tang Y, Zhang L, Forsyth CB, Shaikh M, Song S, Keshavarzian A
    Alcohol. Clin. Exp. Res.
    2015 Sep
  3. Structural features of soluble cereal arabinoxylan fibers associated with a slow rate of in vitro fermentation by human fecal microbiota.
    Rumpagaporn P, Reuhs BL, Kaur A, Patterson JA, Keshavarzian A, Hamaker BR
    Carbohydr Polym
    2015 Oct 5
  4. Chronic Alcohol Exposure and the Circadian Clock Mutation Exert Tissue-Specific Effects on Gene Expression in Mouse Hippocampus, Liver, and Proximal Colon.
    Summa KC, Jiang P, Fitzpatrick K, Voigt RM, Bowers SJ, Forsyth CB, Vitaterna MH, Keshavarzian A, Turek FW
    Alcohol. Clin. Exp. Res.
    2015 Oct
  5. Decreased melatonin secretion is associated with increased intestinal permeability and marker of endotoxemia in alcoholics.
    Swanson GR, Gorenz A, Shaikh M, Desai V, Forsyth C, Fogg L, Burgess HJ, Keshavarzian A
    Am. J. Physiol. Gastrointest. Liver Physiol.
    2015 Jun 15
  6. Longitudinal Survey of Microbiota in Hospitalized Preterm Very Low Birth Weight Infants.
    Patel AL, Mutlu EA, Sun Y, Koenig L, Green S, Jakubowicz A, Mryan J, Engen P, Fogg L, Chen AL, Pombar X, Meier PP, Keshavarzian A
    J. Pediatr. Gastroenterol. Nutr.
    2015 Jul 29
  7. Minimum Requirements for Reporting Fecal Microbiota Transplant Trial.
    Moossavi S, Bishehsari F, Ansari R, Vahedi H, Nasseri-Moghaddam S, Merat S, Sobhani I, Keshavarzian A, Malekzadeh R
    Middle East J Dig Dis
    2015 Jul
  8. Disease-specific alterations in the enteric virome in inflammatory bowel disease.
    Norman JM, Handley SA, Baldridge MT, Droit L, Liu CY, Keller BC, Kambal A, Monaco CL, Zhao G, Fleshner P, Stappenbeck TS, McGovern DP, Keshavarzian A, Mutlu EA, Sauk J, Gevers D, Xavier RJ, Wang D, Parkes M, Virgin HW
    2015 Jan 29
  9. Intestinal Microbiota: a Regulator of Intestinal Inflammation and Cardiac Ischemia?
    Bashashati M, Habibi HR, Keshavarzian A, Schmulson M, Sharkey KA
    Curr Drug Targets
    2015 Jan 19
  10. HIV-associated mucosal gene expression: region-specific alterations.
    Voigt RM, Keshavarzian A, Losurdo J, Swanson G, Siewe B, Forsyth CB, French AL, Demarais P, Engen P, Raeisi S, Mutlu E, Landay AL
    2015 Jan 14
  11. Simultaneous gas-chromatographic urinary measurement of sugar probes to assess intestinal permeability: Use of time course analysis to optimize its use to assess regional gut permeability.
    Shaikh M, Rajan K, Forsyth CB, Voigt RM, Keshavarzian A
    Clin. Chim. Acta
    2015 Jan 12
  12. Modulation of TIM-3 expression on NK and T cell subsets in HIV immunological non-responders.
    de Kivit S, Lempsink LJ, Plants J, Martinson J, Keshavarzian A, Landay AL
    Clin. Immunol.
    2015 Jan
  13. Chronic alcohol consumption induces osteoarthritis-like pathological changes in an experimental mouse model.
    Kc R, Voigt R, Ellman MB, Li X, Summa KC, Forsyth CB, Keshavarzian A, Turek FW, Kim JS, Im HJ
    2015 Feb 23
  14. Response to Dr. Kawada.
    Swanson G, Rizvydeen M, Burgess H, Keshavarzian A
    Am. J. Physiol. Gastrointest. Liver Physiol.
    2015 Aug 15
  15. Getting personal: a review of sexual functioning, body image, and their impact on quality of life in patients with inflammatory bowel disease.
    Jedel S, Hood MM, Keshavarzian A
    Inflamm. Bowel Dis.
    2015 Apr
  16. Classification methods for the analysis of LH-PCR data associated with inflammatory bowel disease patients.
    Wisittipanit N, Rangwala H, Sikaroodi M, Keshavarzian A, Mutlu EA, Gillevet P
    Int J Bioinform Res Appl
  17. Abnormal lipopolysaccharide binding protein as marker of gastrointestinal inflammation in Parkinson disease.
    Pal GD, Shaikh M, Forsyth CB, Ouyang B, Keshavarzian A, Shannon KM
    Front Neurosci
  18. Alcohol Induced Alterations to the Human Fecal VOC Metabolome.
    Couch RD, Dailey A, Zaidi F, Navarro K, Forsyth CB, Mutlu E, Engen PA, Keshavarzian A
    PLoS ONE
  19. Supplementation of Saturated Long-chain Fatty Acids Maintains Intestinal Eubiosis and Reduces Ethanol-induced Liver Injury in Mice.
    Chen P, Torralba M, Tan J, Embree M, Zengler K, Stärkel P, Pijkeren JP, DePew J, Loomba R, Ho SB, Bajaj JS, Mutlu EA, Keshavarzian A, Tsukamoto H, Nelson KE, Fouts DE, Schnabl B
    2014 Sep 16
  20. The role of miRNAs in alcohol-induced endotoxemia, dysfunction of mucosal immunity, and gut leakiness.
    Tang Y, Forsyth CB, Keshavarzian A
    Alcohol. Clin. Exp. Res.
    2014 Sep
  21. Hepatitis B vaccination in patients with inflammatory bowel disease.
    Ben Musa R, Gampa A, Basu S, Keshavarzian A, Swanson G, Brown M, Abraham R, Bruninga K, Losurdo J, DeMeo M, Mobarhan S, Shapiro D, Mutlu E
    World J. Gastroenterol.
    2014 Nov 7
  22. Circadian rhythms, alcohol and gut interactions.
    Forsyth CB, Voigt RM, Burgess HJ, Swanson GR, Keshavarzian A
    2014 Nov 14
  23. In vitro evaluation of intestinal epithelial TLR activation in preventing food allergic responses.
    de Kivit S, Tobin MC, DeMeo MT, Fox S, Garssen J, Forsyth CB, Keshavarzian A, Landay AL
    Clin. Immunol.
    2014 Jul 21
  24. ß-Catenin promotes colitis and colon cancer through imprinting of proinflammatory properties in T cells.
    Keerthivasan S, Aghajani K, Dose M, Molinero L, Khan MW, Venkateswaran V, Weber C, Emmanuel AO, Sun T, Bentrem DJ, Mulcahy M, Keshavarzian A, Ramos EM, Blatner N, Khazaie K, Gounari F
    Sci Transl Med
    2014 Feb 26
  25. A compositional look at the human gastrointestinal microbiome and immune activation parameters in HIV infected subjects.
    Mutlu EA, Keshavarzian A, Losurdo J, Swanson G, Siewe B, Forsyth C, French A, Demarais P, Sun Y, Koenig L, Cox S, Engen P, Chakradeo P, Abbasi R, Gorenz A, Burns C, Landay A
    PLoS Pathog.
    2014 Feb
  26. Intestinal CYP2E1: A mediator of alcohol-induced gut leakiness.
    Forsyth CB, Voigt RM, Keshavarzian A
    Redox Biol
  27. Regulation of Intestinal Immune Responses through TLR Activation: Implications for Pro- and Prebiotics.
    de Kivit S, Tobin MC, Forsyth CB, Keshavarzian A, Landay AL
    Front Immunol
  28. Circadian disorganization alters intestinal microbiota.
    Voigt RM, Forsyth CB, Green SJ, Mutlu E, Engen P, Vitaterna MH, Turek FW, Keshavarzian A
    PLoS ONE
  29. An Esophagogastroduodenal Crohn's-Like Disease in a Long-Standing Pan-Ulcerative Colitis Patient.
    Moore C, Jakate S, Keshavarzian A
    Case Rep Gastrointest Med
  30. CYP2E1 potentiates binge alcohol-induced gut leakiness, steatohepatitis, and apoptosis.
    Abdelmegeed MA, Banerjee A, Jang S, Yoo SH, Yun JW, Gonzalez FJ, Keshavarzian A, Song BJ
    Free Radic. Biol. Med.
    2013 Sep 21
  31. Impact of dietary fiber fermentation from cereal grains on metabolite production by the fecal microbiota from normal weight and obese individuals.
    Yang J, Keshavarzian A, Rose DJ
    J Med Food
    2013 Sep
  32. Progression of intestinal permeability changes and alpha-synuclein expression in a mouse model of Parkinson's disease.
    Kelly LP, Carvey PM, Keshavarzian A, Shannon KM, Shaikh M, Bakay RA, Kordower JH
    Mov. Disord.
    2013 Nov 4
  33. Diagnostic Medical Radiation in Inflammatory Bowel Disease: How to Limit Risk and Maximize Benefit.
    Swanson G, Behara R, Braun R, Keshavarzian A.
    Inflamm Bowel Dis. 2013
    2013 Jun 20. [Epub ahead of print]
  34. In vitro characterization of the impact of selected dietary fibers on fecal microbiota composition and short chain fatty acid production.
    Yang J, Martínez I, Walter J, Keshavarzian A, Rose DJ
    2013 Jul 4
  35. Role for intestinal CYP2E1 in alcohol-induced circadian gene-mediated intestinal hyperpermeability.
    Forsyth CB, Voigt RM, Shaikh M, Tang Y, Cederbaum AI, Turek FW, Keshavarzian A
    Am. J. Physiol. Gastrointest. Liver Physiol.
    2013 Jul 15
  36. Ethanol-induced mast cell-mediated inflammation leads to increased susceptibility of intestinal tumorigenesis in the APC ?468 min mouse model of colon cancer.
    Wimberly AL, Forsyth CB, Khan MW, Pemberton A, Khazaie K, Keshavarzian A.
    Alcohol Clin Exp Res. 2013
    2013 Jan
    37 Suppl 1:E199-208. doi: 10.1111/j.1530-0277.2012.01894.x.
  37. Regulatory B cell frequency correlates with markers of HIV disease progression and attenuates anti-HIV CD8+ T cell function in vitro.
    Siewe B, Stapleton JT, Martinson J, Keshavarzian A, Kazmi N, Demarais PM, French AL, Landay A.
    J Leukoc Biol. 2013
    2013 Feb 22. [Epub ahead of print]
  38. A Role for TLR Signaling During B Cell Activation in Antiretroviral-Treated HIV Individuals.
    Siewe B, Keshavarzian A, French A, Demarais P, Landay A
    AIDS Res. Hum. Retroviruses
    2013 Aug 16
  39. PI3K/AKT Signaling Is Essential for Communication between Tissue-Infiltrating Mast Cells, Macrophages, and Epithelial Cells in Colitis-Induced Cancer.
    Khan MW, Keshavarzian A, Gounaris E, Melson JE, Cheon EC, Blatner NR, Chen ZE, Tsai FN, Lee G, Ryu H, Barrett TA, Bentrem DJ, Beckhove P, Khazaie K.
    Clin Cancer Res. 2013
    2013 Apr 12. [Epub ahead of print]
  40. Investing in academic medicine research mentoring: low cost, high return.
    Skarupski KA, Keshavarzian A.
    Gastroenterology. 2013
    2013 Apr
    144(4):e21-2. doi: 10.1053/j.gastro.2013.01.064. Epub 2013 Feb 24. No abstract available.
  41. Chronic alcohol exposure renders epithelial cells vulnerable to bacterial infection.
    Wood S, Pithadia R, Rehman T, Zhang L, Plichta J, Radek KA, Forsyth C, Keshavarzian A, Shafikhani SH.
    PLoS One. 2013
    8(1):e54646. doi: 10.1371/journal.pone.0054646. Epub 2013 Jan 24.
  42. Disruption of the Circadian Clock in Mice Increases Intestinal Permeability and Promotes Alcohol-Induced Hepatic Pathology and Inflammation.
    Summa KC, Voigt RM, Forsyth CB, Shaikh M, Cavanaugh K, Tang Y, Vitaterna MH, Song S, Turek FW, Keshavarzian A
    PLoS ONE
  43. The approach to sample acquisition and its impact on the derived human fecal microbiome and VOC metabolome.
    Couch RD, Navarro K, Sikaroodi M, Gillevet P, Forsyth CB, Mutlu E, Engen PA, Keshavarzian A
    PLoS ONE
  44. Circadian disruption: potential implications in inflammatory and metabolic diseases associated with alcohol.
    Voigt RM, Forsyth CB, Keshavarzian A
    Alcohol Res
  45. Inpatient capsule endoscopy leads to frequent incomplete small bowel examinations.
    Yazici C, Losurdo J, Brown MD, Oosterveen S, Rahimi R, Keshavarzian A, Bozorgnia L, Mutlu E.
    World J Gastroenterol. 2012
    2012 Sep 28
    18(36):5051-7. doi: 10.3748/wjg.v18.i36.5051.
  46. Colonic microbiome is altered in alcoholism.
    Mutlu EA, Gillevet PM, Rangwala H, Sikaroodi M, Naqvi A, Engen PA, Kwasny M, Lau CK, Keshavarzian A.
    Am J Physiol Gastrointest Liver Physiol. 2012
    2012 May 1
    302(9):G966-78. doi: 10.1152/ajpgi.00380.2011. Epub 2012 Jan 12.
  47. Alpha-synuclein in colonic submucosa in early untreated Parkinson's disease.
    Shannon KM, Keshavarzian A, Mutlu E, Dodiya HB, Daian D, Jaglin JA, Kordower JH.
    Mov Disord. 2012
    2012 May
    27(6):709-15. doi: 10.1002/mds.23838. Epub 2011 Jul 15.
  48. Is alpha-synuclein in the colon a biomarker for premotor Parkinson's disease? Evidence from 3 cases.
    Shannon KM, Keshavarzian A, Dodiya HB, Jakate S, Kordower JH.
    Mov Disord. 2012
    2012 May
    27(6):716-9. doi: 10.1002/mds.25020. Epub 2012 May 1.
  49. Addressing the mind, body, and spirit in a gastrointestinal practice for inflammatory bowel disease patients.
    Jedel S, Hankin V, Voigt RM, Keshavarzian A.
    Clin Gastroenterol Hepatol. 2012
    2012 Mar
    10(3):244-6. doi: 10.1016/j.cgh.2011.11.028. Epub 2011 Dec 13. No abstract available.
  50. Unusual thrombotic complications.
    Broucek JR, Francescatti AB, Swanson GR, Keshavarzian A, Brand MI, Saclarides TJ.
    Am Surg. 2012
    2012 Jun
    78(6):728-9. No abstract available.
  51. Lymphogranuloma venereum proctosigmoiditis is a mimicker of inflammatory bowel disease.
    Gallegos M, Bradly D, Jakate S, Keshavarzian A.
    World J Gastroenterol. 2012
    2012 Jul 7
    18(25):3317-21. doi: 10.3748/wjg.v18.i25.3317.
  52. Role of snail activation in alcohol-induced iNOS-mediated disruption of intestinal epithelial cell permeability.
    Forsyth CB, Tang Y, Shaikh M, Zhang L, Keshavarzian A.
    Alcohol Clin Exp Res. 2011
    2011 Sep
    35(9):1635-43. doi: 10.1111/j.1530-0277.2011.01510.x. Epub 2011 Apr 27.
  53. New molecular insights into inflammatory bowel disease-induced diarrhea.
    Tang Y, Forsyth CB, Keshavarzian A.
    Expert Rev Gastroenterol Hepatol. 2011
    2011 Oct
    5(5):615-25. doi: 10.1586/egh.11.64. Review.
  54. Particulate matter air pollution causes oxidant-mediated increase in gut permeability in mice.
    Mutlu EA, Engen PA, Soberanes S, Urich D, Forsyth CB, Nigdelioglu R, Chiarella SE, Radigan KA, Gonzalez A, Jakate S, Keshavarzian A, Budinger GR, Mutlu GM.
    Part Fibre Toxicol. 2011
    2011 Jun 9
    8:19. doi: 10.1186/1743-8977-8-19.
  55. The role of matrix metalloproteinases in intestinal epithelial wound healing during normal and inflammatory states.
    Hayden DM, Forsyth C, Keshavarzian A.
    J Surg Res. 2011
    2011 Jun 15
    168(2):315-24. doi: 10.1016/j.jss.2010.03.002. Epub 2010 Mar 26.
  56. Cap polyposis with protein-losing enteropathy.
    Gallegos M, Lau C, Bradly DP, Blanco L, Keshavarzian A, Jakate SM.
    Gastroenterol Hepatol (N Y). 2011
    2011 Jun
    7(6):415-20. No abstract available.
  57. Role of intestinal circadian genes in alcohol-induced gut leakiness.
    Swanson G, Forsyth CB, Tang Y, Shaikh M, Zhang L, Turek FW, Keshavarzian A.
    Alcohol Clin Exp Res. 2011
    2011 Jul
    35(7):1305-14. doi: 10.1111/j.1530-0277.2011.01466.x. Epub 2011 Apr 4.
  58. The role of oral hygiene in inflammatory bowel disease.
    Singhal S, Dian D, Keshavarzian A, Fogg L, Fields JZ, Farhadi A.
    Dig Dis Sci. 2011
    2011 Jan
    56(1):170-5. doi: 10.1007/s10620-010-1263-9. Epub 2010 May 11.
  59. Sleep disturbances and inflammatory bowel disease: a potential trigger for disease flare?
    Swanson GR, Burgess HJ, Keshavarzian A.
    Expert Rev Clin Immunol. 2011
    2011 Jan
    7(1):29-36. doi: 10.1586/eci.10.83. Review.
  60. Solid-phase microextraction and the human fecal VOC metabolome.
    Dixon E, Clubb C, Pittman S, Ammann L, Rasheed Z, Kazmi N, Keshavarzian A, Gillevet P, Rangwala H, Couch RD.
    PLoS One. 2011
    2011 Apr 8
    6(4):e18471. doi: 10.1371/journal.pone.0018471.
  61. Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson's disease.
    Forsyth CB, Shannon KM, Kordower JH, Voigt RM, Shaikh M, Jaglin JA, Estes JD, Dodiya HB, Keshavarzian A.
    PLoS One. 2011
    6(12):e28032. doi: 10.1371/journal.pone.0028032. Epub 2011 Dec 1.
  62. Is moderate red wine consumption safe in inactive inflammatory bowel disease?
    Swanson GR, Tieu V, Shaikh M, Forsyth C, Keshavarzian A.
    Digestion. 2011
    84(3):238-44. doi: 10.1159/000329403. Epub 2011 Aug 26.
  63. Histopathology predictors of medically refractory ulcerative colitis.
    Melson JE, Giusto D, Kwasny M, Eichenseer P, Jakate S, Keshavarzian A.
    Dis Colon Rectum. 2010
    2010 Sep
    53(9):1280-6. doi: 10.1007/DCR.0b013e3181e751df.
  64. Apoptosis and inflammation: role of adipokines in inflammatory bowel disease.
    Ponemone V, Keshavarzian A, Brand MI, Saclarides T, Abcarian H, Cabay RJ, Fletcher E, Larsen B, Durstine LJ, Fantuzzi G, Fayad R.
    Clin Transl Gastroenterol. 2010
    2010 Oct 21
    1:e1. doi: 10.1038/ctg.2010.1.
  65. Pattern of alcohol consumption and its effect on gastrointestinal symptoms in inflammatory bowel disease.
    Swanson GR, Sedghi S, Farhadi A, Keshavarzian A.
    Alcohol. 2010
    2010 May
    44(3):223-8. doi: 10.1016/j.alcohol.2009.10.019.
  66. Network-based modeling of the human gut microbiome.
    Naqvi A, Rangwala H, Keshavarzian A, Gillevet P.
    Chem Biodivers. 2010
    2010 May
    7(5):1040-50. doi: 10.1002/cbdv.200900324.
  67. Quantitative assessment of the human gut microbiome using multitag pyrosequencing.
    Gillevet P, Sikaroodi M, Keshavarzian A, Mutlu EA.
    Chem Biodivers. 2010
    2010 May
    7(5):1065-75. doi: 10.1002/cbdv.200900322.
  68. Starch-entrapped microspheres show a beneficial fermentation profile and decrease in potentially harmful bacteria during in vitro fermentation in faecal microbiota obtained from patients with inflammatory bowel disease.
    Rose DJ, Venema K, Keshavarzian A, Hamaker BR.
    Br J Nutr. 2010
    2010 May
    103(10):1514-24. doi: 10.1017/S0007114509993515. Epub 2009 Dec 21.
  69. Endogenous melatonin profiles in asymptomatic inflammatory bowel disease.
    Burgess HJ, Swanson GR, Keshavarzian A.
    Scand J Gastroenterol. 2010
    2010 Jun
    45(6):759-61. doi: 10.3109/00365521003749818. No abstract available.
  70. Alcohol stimulates activation of Snail, epidermal growth factor receptor signaling, and biomarkers of epithelial-mesenchymal transition in colon and breast cancer cells.
    Forsyth CB, Tang Y, Shaikh M, Zhang L, Keshavarzian A.
    Alcohol Clin Exp Res. 2010
    2010 Jan
    34(1):19-31. doi: 10.1111/j.1530-0277.2009.01061.x. Epub 2009 Oct 23.
  71. Effects of aspirin on gastroduodenal permeability in alcoholics and controls.
    Farhadi A, Keshavarzian A, Kwasny MJ, Shaikh M, Fogg L, Lau C, Fields JZ, Forsyth CB.
    Alcohol. 2010
    2010 Aug
    44(5):447-56. doi: 10.1016/j.alcohol.2010.05.004. Epub 2010 Jul 3.
  72. Laparoscopic transgastric esophageal mucosal resection: 4-year minimum follow-up.
    Frantzides CT, Carlson MA, Keshavarzian A, Roberts JE.
    Am J Surg. 2010
    2010 Aug
    200(2):305-7. doi: 10.1016/j.amjsurg.2009.10.011. Epub 2010 Feb 25.
  73. MicroRNAs: master regulators of ethanol abuse and toxicity?
    Miranda RC, Pietrzykowski AZ, Tang Y, Sathyan P, Mayfield D, Keshavarzian A, Sampson W, Hereld D.
    Alcohol Clin Exp Res. 2010
    2010 Apr
    34(4):575-87. doi: 10.1111/j.1530-0277.2009.01126.x. Epub 2010 Jan 26. Review.
  74. Current therapeutic approaches in inflammatory bowel disease.
    Sohrabpour AA, Malekzadeh R, Keshavarzian A.
    Curr Pharm Des. 2010
  75. Intestinal dysbiosis: a possible mechanism of alcohol-induced endotoxemia and alcoholic steatohepatitis in rats.
    Mutlu E, Keshavarzian A, Engen P, Forsyth CB, Sikaroodi M, Gillevet P.
    Alcohol Clin Exp Res. 2009
    2009 Oct
    33(10):1836-46. doi: 10.1111/j.1530-0277.2009.01022.x. Epub 2009 Jul 23.
  76. Starch-entrapped microspheres extend in vitro fecal fermentation, increase butyrate production, and influence microbiota pattern.
    Rose DJ, Keshavarzian A, Patterson JA, Venkatachalam M, Gillevet P, Hamaker BR.
    Mol Nutr Food Res. 2009
    2009 May
    53 Suppl 1:S121-30. doi: 10.1002/mnfr.200800033.
  77. Lactobacillus GG treatment ameliorates alcohol-induced intestinal oxidative stress, gut leakiness, and liver injury in a rat model of alcoholic steatohepatitis.
    Forsyth CB, Farhadi A, Jakate SM, Tang Y, Shaikh M, Keshavarzian A.
    Alcohol. 2009
    2009 Mar
    43(2):163-72. doi: 10.1016/j.alcohol.2008.12.009.
  78. Evidence that chronic alcohol exposure promotes intestinal oxidative stress, intestinal hyperpermeability and endotoxemia prior to development of alcoholic steatohepatitis in rats.
    Keshavarzian A, Farhadi A, Forsyth CB, Rangan J, Jakate S, Shaikh M, Banan A, Fields JZ.
    J Hepatol. 2009
    2009 Mar
    50(3):538-47. doi: 10.1016/j.jhep.2008.10.028. Epub 2008 Dec 29.
  79. SIMDOT-AbMe: microphysiologically based simulation tool for quantitative prediction of systemic and local bioavailability of targeted oral delivery formulations.
    Haddish-Berhane N, Farhadi A, Nyquist C, Haghighi K, Keshavarzian A.
    Drug Metab Dispos. 2009
    2009 Mar
    37(3):608-18. doi: 10.1124/dmd.108.021949. Epub 2008 Dec 1.
  80. Oats supplementation prevents alcohol-induced gut leakiness in rats by preventing alcohol-induced oxidative tissue damage.
    Tang Y, Forsyth CB, Banan A, Fields JZ, Keshavarzian A.
    J Pharmacol Exp Ther. 2009
    2009 Jun
    329(3):952-8. doi: 10.1124/jpet.108.148643. Epub 2009 Mar 10.
  81. Sleep deprivation worsens inflammation and delays recovery in a mouse model of colitis.
    Tang Y, Preuss F, Turek FW, Jakate S, Keshavarzian A.
    Sleep Med. 2009
    2009 Jun
    10(6):597-603. doi: 10.1016/j.sleep.2008.12.009. Epub 2009 Apr 28.
  82. Nitric oxide-mediated intestinal injury is required for alcohol-induced gut leakiness and liver damage.
    Tang Y, Forsyth CB, Farhadi A, Rangan J, Jakate S, Shaikh M, Banan A, Fields JZ, Keshavarzian A.
    Alcohol Clin Exp Res. 2009
    2009 Jul
    33(7):1220-30. doi: 10.1111/j.1530-0277.2009.00946.x. Epub 2009 Apr 9.
  83. Reconsidering the methodology of stress research in inflammatory bowel disease.
    Keefer L, Keshavarzian A, Mutlu E.
    J Crohns Colitis. 2008
    2008 Sep
    2(3):193-201. doi: 10.1016/j.crohns.2008.01.002. Epub 2008 Mar 10.
  84. Atopic irritable bowel syndrome: a novel subgroup of irritable bowel syndrome with allergic manifestations
    Tobin MC, Moparty B, Farhadi A, DeMeo MT, Bansal PJ, Keshavarzian A
    Ann Allergy Asthma Immunol
    2008 Jan
  85. Effect of alcohol on miR-212 expression in intestinal epithelial cells and its potential role in alcoholic liver disease.
    Tang Y, Banan A, Forsyth CB, Fields JZ, Lau CK, Zhang LJ, Keshavarzian A.
    Alcohol Clin Exp Res. 2008
    2008 Feb
    32(2):355-64. Epub 2007 Dec 21.
  86. Adverse effects of chronic circadian desynchronization in animals in a challenging environment.
    Preuss F, Tang Y, Laposky AD, Arble D, Keshavarzian A, Turek FW.
    Am J Physiol Regul Integr Comp Physiol. 2008
    2008 Dec
    295(6):R2034-40. doi: 10.1152/ajpregu.00118.2008. Epub 2008 Oct 8.
  87. Susceptibility to gut leakiness: a possible mechanism for endotoxaemia in non-alcoholic steatohepatitis.
    Farhadi A, Gundlapalli S, Shaikh M, Frantzides C, Harrell L, Kwasny MM, Keshavarzian A.
    Liver Int. 2008
    2008 Aug
    28(7):1026-33. doi: 10.1111/j.1478-3231.2008.01723.x. Epub 2008 Apr 7.
  88. Alcohol, intestinal bacterial growth, intestinal permeability to endotoxin, and medical consequences: summary of a symposium.
    Purohit V, Bode JC, Bode C, Brenner DA, Choudhry MA, Hamilton F, Kang YJ, Keshavarzian A, Rao R, Sartor RB, Swanson C, Turner JR.
    Alcohol. 2008
    2008 Aug
    42(5):349-61. doi: 10.1016/j.alcohol.2008.03.131. Epub 2008 May 27.
  • (If you cannot play the video, you may need to update to the latest version of Adobe Flash Player.)
  • View Transcript
Patient feedback information is available for physicians employed by Rush University Medical Center who have received 30 or more patient surveys. Responses are measured on a scale of 1 to 5, with 5 being the best score.
Number of Patient Surveys
Friendliness/courtesy of the care provider
Explanations the care provider gave you about your problem or condition
Concern the care provider showed for your questions or worries
Likelihood of your recommending this care provider to others
Care provider's efforts to include you in decisions about your treatment
Information the care provider gave you about medications
Instructions the care provider gave you about follow-up care
Your confidence in this care provider
Degree to which care provider talked with you using words you could understand
Amount of time the care provider spent with you
For more information about patient feedback, see the Quality Care section of the Rush University Medical Center website.